Insider Know

Outsider no-know :)

Dangers Yaz Imposed by Big Pharma

Reports of Yaz side effects continue to develop as the manufacturers of Yaz, Yasmin and Ocella ready themselves for further litigation and more possible lawsuits. Bayer Healthcare Pharmaceuticals, makers of Yasmin and Yaz, and Barr Pharmaceuticals, makers of the generic version Ocella have been barraged with allegement ranging from downplaying the severeness of side effects in their adverts to wittingly unleashing a serious and potentially fatal product on American women.

Among the other arguments impending on Yasmin, Yaz and Ocella birth control, the drugs also include drospirenone, an ingredient not in other oral contraceptives. The British Medical Journal issued studies in August 2009 exhibiting an increased risk of venous blood clots in young women taking drospirenone as opposed to those who used other oral contraceptives. In that same month, the Food & Drug Administration issued an non-related warning letter to Bayer Pharmaceuticals, makers of Yasmin, for using low-quality batches of drospirenone from a plant in Germany. For the benefit of public interest and well-being, these articles have been made available free on the internet.

Any women that have been wounded as a result of taking Yaz, Yasmin or Ocella may be entitled to an award. Many attorneys and legal counsel agencies such as thelegaladvocate.com now provide assistance to anyone experiencing side effects and health issues as a direct result of using Yaz contraception. Now that more women across the United States are coming forward and filing suit, the legal system is moving closer to rendering justice for those who were misled by the birth control manufacturers and possibly their doctors.

Bookmark These icons link to social bookmarking sites where readers can share and discover new web pages.
  • OnlyWire
  • Socialize-It
  • Digg
  • del.icio.us
  • Furl
  • StumbleUpon
  • Netscape
  • YahooMyWeb
  • Reddit
  • Slashdot
  • Ma.gnolia
  • RawSugar

No Comments

No comments yet.

Comments RSS

Sorry, the comment form is closed at this time.